Nalaganje...

A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial

STUDY OBJECTIVE: A safe alternative to erythropoiesis‐stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pharmacotherapy
Main Authors: Birgegård, Gunnar, Henry, David, Glaspy, John, Chopra, Rakesh, Thomsen, Lars L., Auerbach, Michael
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2016
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5071650/
https://ncbi.nlm.nih.gov/pubmed/26927900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1729
Oznake: Označite
Brez oznak, prvi označite!